Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa-Reference-Cited by-同舟云学术

Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa

Published:2011-08 Issue:2 Volume:128 Page:191-195
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Karpf Ditte M.,Sørensen Brit B.,Hermit Mette B.,Holmberg Heidi L.,Tranholm Mikael,Bysted Britta V.,Groth Andreas V.,Bjørn Søren E.,Stennicke Henning R.

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Consensus perspectives on prophylactic therapy for haemophilia: summary statement;Berntorp;Haemophilia,2003

2. Optimizing factor prophylaxis for the haemophilia population: where do we stand?;Blanchette;Haemophilia,2004

3. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N Engl J Med,2007

4. Dose and response in haemophilia–optimization of factor replacement therapy;Srivastava;Br J Haematol,2004

5. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors;Konkle;J Thromb Haemost,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice;Journal of Visualized Experiments;2021-09-30

2. Mouse models of hemostasis;Platelets;2020-01-28

3. Sialyltransferase-mediated glycoPEGylation;Polymer-Protein Conjugates;2020

4. The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies;Thrombosis Research;2019-01

5. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia;European Journal of Pharmaceutical Sciences;2018-03